Hospital-acquired Infection Control Market to Swell with an Absolute Dollar Opportunity of over US$ 6 Billion in Next 10 Years, Reveals Future Market Insights

The Hospital-acquired Infection Control Market revenues were estimated at US$ 6.1 Bn in 2022 and is anticipated to grow at a CAGR of 7% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 12.7 Billion. The frequent occurrence of hospital-acquired infections, …

Nearly 2/5th of Endometrial Ablation Market Revenue comes from US and China, Future Market Insights

The Endometrial Ablation Market revenues were estimated at US$ 3.4 Bn in 2023 and is anticipated to grow at a CAGR of 7.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 6.8 Bn. The aggregate revenue from US and China …

Nearly 2/5th of Stair Lifts and Climbing Devices Demand to Comes from the U.S. throughout the analysis period, States Future Market Insights

The Stair Lifts and Climbing Devices market revenues is estimated at US$ 2.2 Billion in 2022 and are projected to grow at a CAGR of 12% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 6.9 Billion. Arthritis affects more than …

Aesthetic Medical Devices Market Value to reach US$ 35 Billion by 2032, growing at a 9.6% CAGR | FMI Report

A recently published study by FMI expects the global Aesthetic Medical Devices Market to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced …

Neurology Clinical Trials Market is expected to reach a valuation of US$ 10.5 billion at a CAGR of 6.3% by 2032 | FMI

The global Neurology Clinical Trials Market is expected to be worth approximately US$ 5.4 billion in 2021. The market is expected to be worth nearly US$ 10.5 billion by the end of 2032, with a CAGR of 6.3% over the next ten years. Over the forecasted period, the neurology clinical trials market is expected to …

Malaria Treatment Market to nearly reach US$ 2.93 Billion by 2033; expected to surge at a 5% CAGR | FMI Report

Malaria Treatment Market is expected to be worth US$ 1.80 billion in 2023, up from US$ 1.72 billion in the fiscal year 2022. From 2023 to 2033, the market is expected to grow at a 5% CAGR, reaching US$ 2.93 billion by the end of that year. Malaria affected over 210 million people worldwide in …

Human Immunodeficiency Virus Type 1 (HIV 1) Market is expected to reach valuation of US$ 62.37 Billion by 2033 | FMI Study

The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is expected to surpass a remarkable valuation of US$ 34.83 billion in 2023, with a compound annual rate of growth (CAGR) of 6% projected from 2023 to 2033. According to the Institute for Health Metrics and Evaluation, the industry’s growth is due to the rising …

Intratumoral Cancer Therapies Market is expected to reach a valuation of US$ 552.36 Billion by 2033 | FMI Study

A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of 10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can be …

Catheter Related Bloodstream Infection (CRBSI) Market is expected to reach a valuation of US$ 80 Billion by 2033 | FMI

The global Catheter Related Bloodstream Infection (CRBSI) Market is expected to generate a market value of US$ 44.67 billion in 2023 and a market value of US$ 80 billion by 2023-2033, at a CAGR of 6%. The increase in the number of people suffering from urinary infections can be attributed to the growth of the …

Embryo Incubator Market to expand at a 5% value CAGR by 2032

The global embryo incubator market is anticipated to be valued at US$ 77.8 million in 2022, rising to US$ 132.9 million by 2032, with a CAGR of 5% from 2022 to 2032. The market’s expansion can be ascribed to an increase in the use of in-vitro fertilisation methods among patients to aid in reproduction. Embryo …